Down 14%, Tesla Good: Is It a Buy-Now Opportunity?
Tesla has fallen about 14% this year, but a dip isn’t a doom signal. Here’s a clear framework to decide if now is the...
Index movements reflect changes in component stock prices, earnings, macro data, and capital flows. This overview highlights the main drivers behind daily swings.
18,176 articlesTesla has fallen about 14% this year, but a dip isn’t a doom signal. Here’s a clear framework to decide if now is the...
Atlassian shares remain under pressure as the company drives cost cuts and pivots to a cloud-focused model. Analysts ...
Wendy's 2026 earnings kickoff for Q1 sheds light on growth drivers, pricing power, and franchise dynamics. This guide...
Two fast-casual leaders are vying for investor attention in 2026. This deep dive compares CAVA Group and Chipotle Mex...
As Vivid Seats reports Q4 2025 results, investors face a pivotal moment. This article breaks down revenue drivers, ma...
As offshore energy demand shifts, investors face a clear choice: TechnipFMC or Valaris. This guide breaks down how ea...
Intel's turnaround gains traction amid AI-driven demand and a narrowing foundry loss gap, fueling a debate about whet...
Tesla faced a rocky period, but a few hopeful indicators suggest the EV leader may be on a steadier path. This articl...
When Apple speaks at WWDC, markets listen. This article breaks down how Apple Just Delivered News about AI strategy, ...
Cathie Wood's selling moves can offer valuable lessons for investors. This article breaks down why cathie wood goes s...
When a company’s founder and CEO sells a chunk of stock, investors want to know what it means for future performance....
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...